Cosme A, Horcajada J P, Vidaur F, Ojeda E, Torrado J, Arenas J I
Service of Gastroenterology, Hospital Nuestra Señora de Aránzazu, San Sebastián, Spain.
Liver. 1995 Jun;15(3):164-7. doi: 10.1111/j.1600-0676.1995.tb00665.x.
We report a case of a woman who showed hepatic and renal AA amyloidosis with a liver adenoma associated with the use of oral contraceptives. A nephrotic syndrome secondary to the renal amyloidosis underwent complete remission 7 years after the withdrawal of oral contraceptive therapy. Twenty-nine months after the initial presentation, the patient was admitted with acute upper abdominal pain and abdominal tenderness. The abdominal ultrasound revealed a subphrenic fluid collection, and a presumptive diagnosis of a ruptured hepatic adenoma was made. The liver adenoma diminished from 8 cm to 1 cm over a 13-year follow up after the discontinuance of oral contraceptive therapy.
我们报告了一例女性患者，该患者出现肝和肾的AA型淀粉样变性，并伴有与口服避孕药使用相关的肝腺瘤。肾淀粉样变性继发的肾病综合征在停用口服避孕药治疗7年后完全缓解。初次就诊29个月后，患者因急性上腹部疼痛和腹部压痛入院。腹部超声显示膈下有液体积聚，初步诊断为肝腺瘤破裂。在停用口服避孕药治疗后的13年随访中，肝腺瘤从8厘米缩小至1厘米。
